Skip to main content

Advertisement

SpringerLink
Log in

Chemotherapy-induced peripheral neuropathy (CIPN) and vitamin B12 deficiency

  • Letter to the editor
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Ferrier J, Pereira V, Busserolles J, Authier N, Balayssac D (2013) Emerging trends in understanding chemotherapy-induced peripheral neuropathy. Curr Pain Headache Rep 17(10):364

    Article  PubMed  Google Scholar 

  2. Cavaletti G, Nicolini G, Marmiroli P (2008) Neurotoxic effects of antineoplastic drugs: the lesson of pre-clinical studies. Front Biosci 13:3506–3524

    Article  CAS  PubMed  Google Scholar 

  3. Schloss J, Colosmio M, Airey C, Masci PP, Linnane AW, Vitetta L (2013) Nutraceuticals and Chemotherapy-induced Peripheral Neuropathy (CIPN): a systematic review. Clin Nutr 32(6):888–893

    Article  CAS  PubMed  Google Scholar 

  4. Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, Colvin LA, Fallon M (2014) Incidence prevalence and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain 155(12):2461–2470

    Article  PubMed  Google Scholar 

  5. Armstrong T, Almadrones L, Gilbert MR (2005) Chemotherapy-induced peripheral neuropathy. Oncol Nurs Forum 32(2):305–311

    Article  PubMed  Google Scholar 

  6. Bhagra A, Rao RD (2007) Chemotherapy-induced neuropathy. Curr Oncol Rep 9(4):290–299

    Article  CAS  PubMed  Google Scholar 

  7. Vasquez S, Guidon M, McHugh E, Lennon O, Grogan L, Breathnach OS (2013) Chemotherapy induced peripheral neuropathy: the modified total neuropathy score in clinical practice. Ir J Med Sci 183(1):53–58

    Article  PubMed  Google Scholar 

  8. Mols F, Beijers T, Lemmens V, van den Hurk CJ, Vreugdenhil G, van de Poll-Franse LV (2013) Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry. J Clin Oncol 31(21):2699–2707

    Article  PubMed  Google Scholar 

  9. Vu T, Amin J, Ramos M, Flener V, Vanyo L, Tisman G (1993) New assay for the rapid determination of plasma holotranscobalamin II levels: preliminary evaluation in cancer patients. Am J Hematol 42(2):202–211

    Article  CAS  PubMed  Google Scholar 

  10. Hastings MM. Nerve Conduction Study Normal Values (2012):https://wiki.umms.med.umich.edu/display/NEURO/Nerve+Conduction+Study+Normal+Values]. Accessed Aug 2014

  11. Baker H, Leevy CB, DeAngelis B, Frank O, Baker ER (1998) Cobalamin (vitamin B12) and holotranscobalamin changes in plasma and liver tissue in alcoholics with liver disease. J Am Coll Nutr 17:235–238

    Article  CAS  PubMed  Google Scholar 

  12. Aaron S, Kumar S, Vijayan J, Jacob J, Alexander M, Gnanamuthu C (2005) Clinical and laboratory features and response to treatment in patients presenting with vitamin B12 deficiency-related neurological syndromes. Neurol India 53(1):55–58

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Acknowledgment goes to Bio Concepts Pty Ltd, for supply of the B vitamin complex supplement for the clinical trial and to the patient.

Conflict of interest

The authors declare no other potential conflicts of interest with respect to research, authorship and/or publication of this article. The authors have received no financial support for the research, authorship and/or publication of this article. Luis Vitetta has received National Institute of Complementary Medicine and National Health and Medical Research Council of Australia competitive funding and Industry support for research into nutraceuticals and herbal medicines. The authors declare that they have full control of all primary data and allow the journal to review the data if requested.

Author information

Authors and Affiliations

  1. The University of Queensland, School of Medicine, Level 5, TRI, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Brisbane, 4102, Australia

    Janet M. Schloss & Maree Colosimo

  2. Medical Oncology Group of Australia, Clinical Oncology Society of Australia, Queensland Clinical Oncology Group, Brisbane, 4000, Australia

    Maree Colosimo

  3. Department of Neurology, Queensland Health, Ned Hanlon Building, RBWH, Herston, Brisbane, 4006, Australia

    Caroline Airey

  4. Medical Research, Medlab, Sydney, 2015, Australia

    Luis Vitetta

  5. Sydney Medical School, The University of Sydney, Sydney, 2006, Australia

    Luis Vitetta

Authors
  1. Janet M. Schloss
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maree Colosimo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Caroline Airey
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Luis Vitetta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Janet M. Schloss.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schloss, J.M., Colosimo, M., Airey, C. et al. Chemotherapy-induced peripheral neuropathy (CIPN) and vitamin B12 deficiency. Support Care Cancer 23, 1843–1850 (2015). https://doi.org/10.1007/s00520-015-2725-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-015-2725-6

Keywords

Search

Navigation